These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8226564

  • 1. Critical appraisal of immunization strategies for prevention of infection in the compromised host.
    Ambrosino DM, Molrine DC.
    Hematol Oncol Clin North Am; 1993 Oct; 7(5):1027-50. PubMed ID: 8226564
    [Abstract] [Full Text] [Related]

  • 2. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [Abstract] [Full Text] [Related]

  • 3. Critical appraisal of antimicrobials for prevention of infections in immunocompromised hosts.
    Hathorn JW.
    Hematol Oncol Clin North Am; 1993 Oct; 7(5):1051-99. PubMed ID: 8226565
    [Abstract] [Full Text] [Related]

  • 4. Approach to the immunocompromised host with infection in the intensive care unit.
    Linden PK.
    Infect Dis Clin North Am; 2009 Sep; 23(3):535-56. PubMed ID: 19665082
    [Abstract] [Full Text] [Related]

  • 5. Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation.
    Ilan Y, Nagler A, Adler R, Naparstek E, Or R, Slavin S, Brautbar C, Shouval D.
    Hepatology; 1993 Aug; 18(2):246-52. PubMed ID: 8340054
    [Abstract] [Full Text] [Related]

  • 6. Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation.
    Molrine DC, Guinan EC, Antin JH, Wheeler C, Parsons SK, Weinstein HJ, McGarigle C, Blanding P, Phillips NR, Ciamarra A, George S, Ambrosino DM.
    Bone Marrow Transplant; 1996 Jun; 17(6):1149-55. PubMed ID: 8807128
    [Abstract] [Full Text] [Related]

  • 7. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
    Anderson LD, Mori S, Mann S, Savary CA, Mullen CA.
    Cancer Res; 2000 Oct 15; 60(20):5797-802. PubMed ID: 11059776
    [Abstract] [Full Text] [Related]

  • 8. Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.
    Antin JH, Guinan EC, Avigan D, Soiffer RJ, Joyce RM, Martin VJ, Molrine DC.
    Biol Blood Marrow Transplant; 2005 Mar 15; 11(3):213-22. PubMed ID: 15744240
    [Abstract] [Full Text] [Related]

  • 9. Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donors.
    Shouval D, Adler R, Ilan Y.
    Hepatology; 1993 Jun 15; 17(6):955-9. PubMed ID: 8514268
    [Abstract] [Full Text] [Related]

  • 10. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M, Peracchi M, Tridello G, Pillon M, Fregonese F, D'Elia R, Zanesco L, Cesaro S.
    Cancer; 2004 Aug 01; 101(3):635-41. PubMed ID: 15274078
    [Abstract] [Full Text] [Related]

  • 11. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS, Ashman RB.
    Oral Microbiol Immunol; 2005 Dec 01; 20(6):376-81. PubMed ID: 16238599
    [Abstract] [Full Text] [Related]

  • 12. Prospects for prevention of childhood infections by maternal immunization.
    Healy CM, Baker CJ.
    Curr Opin Infect Dis; 2006 Jun 01; 19(3):271-6. PubMed ID: 16645489
    [Abstract] [Full Text] [Related]

  • 13. Vaccination of the solid organ transplant recipient.
    Sester M, Gärtner BC, Girndt M, Sester U.
    Transplant Rev (Orlando); 2008 Oct 01; 22(4):274-84. PubMed ID: 18684606
    [Abstract] [Full Text] [Related]

  • 14. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E, Shattock AG, Fielding JF.
    Am J Gastroenterol; 2000 Jan 01; 95(1):223-6. PubMed ID: 10638588
    [Abstract] [Full Text] [Related]

  • 15. A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation.
    Parkkali T, Käyhty H, Hovi T, Olander RM, Roivainen M, Volin L, Ruutu T, Lahdenkari M, Ruutu P.
    Bone Marrow Transplant; 2007 Feb 01; 39(3):179-88. PubMed ID: 17211432
    [Abstract] [Full Text] [Related]

  • 16. Prospects for development of vaccines against fungal diseases.
    Dan JM, Levitz SM.
    Drug Resist Updat; 2006 Jun 01; 9(3):105-10. PubMed ID: 16820318
    [Abstract] [Full Text] [Related]

  • 17. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation.
    Vance E, George S, Guinan EC, Wheeler C, Antin JH, Ambrosino DM, Molrine DC.
    Bone Marrow Transplant; 1998 Oct 01; 22(8):735-41. PubMed ID: 9827969
    [Abstract] [Full Text] [Related]

  • 18. Reimmunization after blood or marrow stem cell transplantation.
    Singhal S, Mehta J.
    Bone Marrow Transplant; 1999 Apr 01; 23(7):637-46. PubMed ID: 10218839
    [Abstract] [Full Text] [Related]

  • 19. Infection in the compromised host--an overview.
    Kottra CJ.
    Heart Lung; 1983 Jan 01; 12(1):10-4. PubMed ID: 6549629
    [Abstract] [Full Text] [Related]

  • 20. [Post-vaccination immunity after allogenic and autologous bone marrow transplantation].
    Skovránková J.
    Cas Lek Cesk; 1999 May 10; 138(10):298-300. PubMed ID: 10422338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.